documents

in page functions
1 - 25 of 26 matches Page: 1 2 

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

18 December 2008

TPP Master Table

The master table of the target product profile (TPP), product specifications, relate to the public health impact and suitability of the product. 

18 December 2008

TPP Supplementary Information

Supplementary informational for the target product profile (TPP) including general information, vaccine characteristics relevant to the TPP, contributors and WHO policy documents. 

11 December 2008

Minutes from December 2008 meeting

Minutes from the AMC Independent Assessment Committee (IAC) meeting on 11 December 2008.

30 November 2008

TPP Codebook

Codebook to assess whether a pneumococcal vaccine meets the Pneumococcal AMC Target Product Profile for regional vaccine serotype coverage.

13 November 2008

Monitoring and Evaluability Study

The report was commissioned by the Monitoring & Evaluation Subgroup of the AMC Donor Committee in August 2007. The monitoring and evaluation proposals contained in this report have been designed to enable the effectiveness, efficiency and eventual impact of this pilot AMC to be measured over time and to assist with its effective management.

03 November 2008

Minutes from November 2008 meeting

Minutes from the AMC Independent Assessment Committee (IAC) meeting on 3 November 2008.

29 October 2008

Vaccine Investment Strategy - Rabies analysis

Applied Strategies Consulting Project - Vaccine Investment Strategy - Rabies analysis

29 October 2008

Vaccine Investment Strategy - Japanese Encephalitis Analysis

Applied Strategies Consulting Project - Vaccine Investment Strategy - Japanese Encephalitis Analysis

29 October 2008

Vaccine investment strategy - Vaccine Portfolio Analysis

GAVI Vaccine Investment Strategy --  Project Vaccine Portfolio Analysis by Applied Strategies.

29 October 2008

Vaccine investment strategy - Executive summary

Vaccine investment strategy - Executive summary

27 October 2008

Vaccine Investment Strategy - Typhoid analysis

Applied Strategies Consulting Project - Vaccine Investment Strategy - Typhoid analysis

27 October 2008

Vaccine Investment Strategy - HPV analysis documentation

Applied Strategies Consultancy Projecton GAVI's Vaccine Investment Strategy for the human papillomavirus.

27 October 2008

Cholera analysis documentation

Cholera analysis presentation from Applied Strategies Consulting.

20 October 2008

First GAVI Evaluation 2000-2005 - Secretariat response

This evaluation was commissioned by the GAVI Board to: identify and learn from the successes and weaknesses of GAVI in Phase 1, including how well it has evolved and learned from experience over the period 2000-2005; contribute to the refinement or adjustment of GAVI policies in the next strategic phase of work; and document the impact and to evaluate the efficiency and effectiveness of the GAVI Alliance’s use of resources during Phase 1.

20 October 2008

First GAVI Evaluation 2000-2005

This evaluation was commissioned by the GAVI Board to: identify and learn from the successes and weaknesses of GAVI in Phase 1, including how well it has evolved and learned from experience over the period 2000-2005; contribute to the refinement or adjustment of GAVI policies in the next strategic phase of work; and document the impact and to evaluate the efficiency and effectiveness of the GAVI Alliance’s use of resources during Phase 1.

20 October 2008

First GAVI Evaluation 2000-2005 - Executive Summary

This evaluation was commissioned by the GAVI Board to: identify and learn from the successes and weaknesses of GAVI in Phase 1, including how well it has evolved and learned from experience over the period 2000-2005; contribute to the refinement or adjustment of GAVI policies in the next strategic phase of work; and document the impact and to evaluate the efficiency and effectiveness of the GAVI Alliance’s use of resources during Phase 1.

29 September 2008

Vaccine Investment Strategy - Working Group Review, Washington DC 29-30 September 2008

The working group met in Washington DC to review the methodology and outcomes of the analyses performed as part of the Vaccine Investment Strategy project and to provide guidance and feedback to the Secretariat on a recommendation for the GAVI Board.

01 August 2008

Strengthening technical support-Appendix

Lists four appendix for GAVI's strengthening technical support review: technical support provider and procurer profiles; interview notes; survey results; and literature review.

01 August 2008

Monitoring and evaluability study for GAVI's health system support to countries

The overarching objective of this evaluability study is to present an actionable monitoring and evaluation framework and plan for GAVI health system strengthening support.

01 August 2008

Monitoring and evaluability study for GAVI's support for CSOs

The monitoring and evaluability study for the GAVI Support to CSOs and related monitoring and evaluation (M&E) plan are intended to guide the development of a sound and practical approach for measuring the progress and effectiveness of the GAVI Support CSOs, both Component A and Component B.

01 August 2008

Strengthening technical support

The objective of this work is to explore opportunities for the GAVI Alliance to strengthen technical support options accessible to Ministries of Health in GAVI-eligible countries. This study defines technical support broadly; including assistance in preparing programmes and grant applications through implementation and evaluation for both short- and long-term efforts. Providers can be domestic, or international.

10 July 2008

Implementation Working Group (IWG) Report

This report presents the group’s operational recommendations to inform donors’ decisions on AMC design and implementation. It is intended as an addendum to the EEG report, rather than a stand-alone document; therefore, readers will find a number of cross-references.

10 July 2008

IWG Joint Donor Statement

 In February 2007, a collective US$1.5 billion for a pilot Advance Market Commitment (AMC) against pneumococcal disease was pledged by the Governments of Italy, the UK, Canada, Russia and Norway, and the Bill & Melinda Gates Foundation. The report recommends the terms on which the AMC will be offered to help developing countries buy new, more effective pneumococcal vaccines.

01 April 2008

Economic Expert Group (EEG) Report

A report prepared by the Economic Expert Group convened by the GAVI Alliance to provide guidance to the pneumococcal AMC donors about key design decisions using new information available from industry consultations, demand forecasts and modeling of returns to industry under various demand and price scenarios.

17 March 2008

All-Party Parlimentary Group on Pneumococcal Disease Report

This report summarises the results of the All-Party Parliamentary Group for Pneumococcal Disease Prevention in the Developing World (APPG) inquiry into pneumococcal disease in the developing world.

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please




close icon

modal window here